 |
Ann Neurol
- JANKOVIC J
Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?
Ann Neurol. 2008;63:267-9.
PubMed
Related articles
- ALBERS MW
, Marder KS
A tale of two etiologies: loss and recovery of olfactory function.
Ann Neurol. 2008;63:132-4.
PubMed
Related articles
BMC Neurol
- HANCOCK DB
, Martin ER, Mayhew GM, Stajich JM, et al
Pesticide exposure and risk of Parkinson's disease: a family-based case-control study.
BMC Neurol. 2008;8:6.
PubMed
Related articles
Abstract available Free Full Text
Brain Res
- SINGH S
, Singh K, Patel S, Patel DK, et al
Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
Brain Res. 2008;.
PubMed
Related articles
Abstract available
J Am Geriatr Soc
- SANTAMATO A
, Ianieri G, Ranieri M, Megna M, et al
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
J Am Geriatr Soc. 2008;56:765-7.
PubMed
Related articles
J Biol Chem
- FEI Q
, McCormack AL, Di Monte DA, Ethell DW, et al
Paraquat neurotoxicity is mediated by a Bak-dependent mechanism.
J Biol Chem. 2008;283:3357-64.
PubMed
Related articles
Abstract available
J Neural Transm
- BAKKER M
, Verstappen CC, Bloem BR, Toni I, et al
Recent advances in functional neuroimaging of gait.
J Neural Transm. 2007;114:1323-31.
PubMed
Related articles
Abstract available
J Neurochem
- CHATURVEDI RK
, Flint Beal M
PPAR: A therapeutic target in Parkinson's disease.
J Neurochem. 2008;.
PubMed
Related articles
Abstract available
- MIYAZAKI S
, Yanagida T, Nunome K, Ishikawa S, et al
DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
J Neurochem. 2008;.
PubMed
Related articles
Abstract available
Lancet Neurol
- PALFI S
Towards gene therapy for Parkinson's disease.
Lancet Neurol. 2008;.
PubMed
Related articles
- MARKS WJ JR
, Ostrem JL, Verhagen L, Starr PA, et al
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.
Lancet Neurol. 2008;.
PubMed
Related articles
Abstract available
Mov Disord
- MORO E
, Piboolnurak P, Lang AE, Lozano AM, et al
Reply: The variability of levodopa response in Parkinson's disease: Is sensitization reversible?
Mov Disord. 2008;.
PubMed
Related articles
- RAETHJEN J
, Austermann K, Witt K, Zeuner KE, et al
Provocation of Parkinsonian tremor.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
- TAN EK
, Lee SS, S FC, Lum SY, et al
Evidence of increased odds of essential tremor in Parkinson's disease.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
- ISHIHARA T
, Ozawa T, Igarashi S, Kitsukawa Y, et al
Atypical Parkinsonism in distal myopathy with rimmed vacuoles.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
- RODRIGUEZ-OROZ MC
, Rodriguez M, Leiva C, Rodriguez-Palmero M, et al
Neuronal activity of the red nucleus in Parkinson's disease.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
- VAN DE WARRENBURG BP
, Church AJ, Martino D, Candler PM, et al
Antineuronal antibodies in Parkinson's disease.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
- SKODDA S
, Schlegel U
Speech rate and rhythm in Parkinson's disease.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
- HUANG X
, Abbott RD, Petrovitch H, Mailman RB, et al
Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
- PAGONABARRAGA J
, Kulisevsky J, Llebaria G, Garcia-Sanchez C, et al
Parkinson's disease-cognitive rating scale: A new cognitive scale specific for Parkinson's disease.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
- GILL DJ
, Freshman A, Blender JA, Ravina B, et al
The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease.
Mov Disord. 2008;.
PubMed
Related articles
Abstract available
Nat Clin Pract Neurol
- BROOKS DJ
Technology Insight: imaging neurodegeneration in Parkinson's disease.
Nat Clin Pract Neurol. 2008;.
PubMed
Related articles
Abstract available
Nat Med
- TABAR V
, Tomishima M, Panagiotakos G, Wakayama S, et al
Therapeutic cloning in individual parkinsonian mice.
Nat Med. 2008;.
PubMed
Related articles
Abstract available
Neurobiol Dis
- PICCONI B
, Paille V, Ghiglieri V, Bagetta V, et al
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation.
Neurobiol Dis. 2008;29:327-35.
PubMed
Related articles
Abstract available
Neurology
- MORO E
, Volkmann J, Konig IR, Winkler S, et al
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
Neurology. 2008;70:1186-91.
PubMed
Related articles
Abstract available
Rev Neurol
- LORENZO-BOSQUET C
, Hernandez-Vara J, Castell-Conesa J, Miquel-Rodriguez F, et al
[Functional neuroimaging with SPECT in Parkinson's disease and Parkinsonisms.]
Rev Neurol. 2008;46:430-5.
PubMed
Related articles
Abstract available Free Full Text